↑ Rising
Health
Ozempic and Wegovy may strengthen bones in Type 2 diabetes patients, study finds
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Wegovy
6 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Health
🔮 fades ✓
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
Research highlights a recurring pattern of patients stopping and restarting GLP-1 weight-loss medications, prompting studies into potential new clinical approaches.
◼ Archived
Health
🔮 holds ✗
Scientists Find Intriguing Link Between Ozempic and Violent Behavior
16 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Ozempic Users Are Skimping Out on Exercise, Study Finds
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.
◼ Archived
Health
🔮 holds ✗
The hidden cost of weight-loss drugs: scurvy, anaemia, bleeding gums
GLP-1 weight-loss drugs are exposing a hidden health crisis: nutrient deficiencies linked to rapid weight loss
◼ Archived
Business
🔮 fades ✓
Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases
US employers may halt GLP-1 drug coverage in 2027 amid rising costs and usage spikes